YANA RYZHAKOVA: Open Payments
NPI 1033576863 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,292 in 106 payments from 17 companies in 2025. Trend: 2023 $3,555 · 2024 $1,448 · 2025 $3,292
Food & beverage: $3,291Education: $1
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 12 | $473 |
| ABBVIE INC. | 9 | $425 |
| Incyte Corporation | 14 | $349 |
| PFIZER INC. | 14 | $348 |
| E.R. Squibb & Sons, L.L.C. | 2 | $245 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 14 | $227 |
| ARS Pharmaceuticals Operations, Inc. | 7 | $210 |
| Phathom Pharmaceuticals, Inc. | 5 | $205 |
| Alkermes, Inc. | 2 | $151 |
| Aimmune Therapeutics, Inc. | 1 | $147 |
Products named: UBRELVY, Opzelura, NURTEC ODT, Auvelity, COBENFY, XIFAXAN, NEFFY, VOQUEZNA.
Industry payments across NY — which companies pay providers there.
